Brigham and Womens Hosp

Boston, Massachusetts 02478

0 studies enrolling now · 24 studies all time

What they study most

Cancer, Chickenpox, HIV Infections, Hyperinsulinemia, Lipodystrophy, Pain, Papilloma, Pregnancy, Pregnancy Complications, Infectious

Studies at this site

• Consent for Use of Stored Patient Specimens for Future Testing — Running, not enrolling
• Adding New Drugs for HIV Infected Patients Failing Current Therapy — Completed
• Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids — Completed
• A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants — Completed
• A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies — Completed
• A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection — Completed
• Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission — Completed
• Long-Term Data Collection From Participants in Adult AIDS Clinical Trials — Completed
• The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women — Completed
• Effects of Changing HIV Therapy at Lower Versus Higher Viral Loads — Completed
• Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities — Completed
• Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients — Completed
• Changing to Nonprotease Inhibitor Treatment to Improve Side Effects — Completed
• Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking a Protease Inhibitor — Completed
• A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT) — Completed
• A Comparison of Two Tests for Anti-HIV Drug Resistance — Completed
• Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women — Completed
• The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection — Completed
• A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain — Completed
• A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3 — Completed
• A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3 — Completed
• Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With Zidovudine — Completed
• A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Patients — Completed
• Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs — Status unconfirmed